Breaking News, Promotions & Moves

Cidara Therapeutics Taps Jim Beitel as Chief Business Officer

Beitel has 20+ years of experience in life science corporate development including strategy, business development, commercialization, finance, and more.

Author Image

By: Charlie Sternberg

Associate Editor

Cidara Therapeutics Inc., a biotechnology company using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies, has named Jim Beitel, MBA, as its Chief Business Officer (CBO).   Preetam Shah, Ph.D., MBA, who has held the roles of both Chief Financial Officer (CFO) and CBO for Cidara since 2021, will continue as the CFO and principal accounting officer overseeing the finance, accounting, and investor relations functions.   “We welcome Jim to Cidara’s executive ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters